dolutegravir
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of adults and children (weighing at least 40 kg) infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR27
Manufacturer: Maylan Laboratories Limited
-
The drug is used for the treatment of adults and children aged 12 years and older (weighing 40 kg or more) who are infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage abacavir 600 mg dolutegravir 50 mg lamivudine 300 mg ATC: J05AR13
Manufacturer: Hetero Labs Limited
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) infected with the human immunodeficiency virus (HIV), in combination with other antiretroviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AX12
Manufacturer: Aurobindo Pharma Limited, Unit-VII
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) infected with the human immunodeficiency virus (HIV), in combination with other antiretroviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AX12
Manufacturer: San Pharmaceutical Industries Limited
-
The drug is used in combination with other antiretroviral agents for the treatment of adults and children aged 12 years and older (or children weighing at least 40 kg) infected with HIV-1.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AJ03
Manufacturer: Maylan Laboratories Limited
-
The drug is intended for adults, adolescents, and children aged 12 years and older for the treatment of HIV-1 infection in combination with other antiretroviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AJ03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of adults infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR
Manufacturer: Aurobindo Pharma Limited - Unit VII
-
Dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets 50 mg/300 mg/300 mg is intended for the treatment of adults and children aged 12 years and older (weighing more than 40 kg) infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 300 mg ATC: J05AR
Manufacturer: Lupin Limited
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing 40 kg or more) who are infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage abacavir 600 mg dolutegravir 50 mg lamivudine 300 mg ATC: J05AR13
Manufacturer: Emkur Pharmaceuticals Ltd
-
Instgra is prescribed for adults and children aged 12 years and older for the treatment of HIV-1 infection in combination with other antiretroviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AX12
Manufacturer: Emkur Pharmaceuticals Ltd.
-
The drug is intended for the treatment of adults and children (from 12 years of age with a body weight of at least 40 kg) infected with human immunodeficiency virus type 1 (HIV-1), in combination with other antiviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg emtricitabine 200 mg tenofovir alafenamide 25 mg ATC: J05AR
Manufacturer: Maylan Laboratories Limited
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) who are infected with the human immunodeficiency virus (HIV), in combination with other antiviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AX12
Manufacturer: Hetero Labs Limited
-
The drug is indicated for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) who are infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 300 mg ATC: J05AR27
Manufacturer: Hetero Labs Limited
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) who are infected with the human immunodeficiency virus (HIV). It is used in combination with other antiretroviral agents.
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg ATC: J05AJ03
-
The drug is intended for the treatment of adults and children aged 12 years and older (weighing 40 kg or more) who are infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg abacavir 600 mg lamivudine 300 mg ATC: J05AR13
Manufacturer: Glaxo Operations UK Limited (manufacturer of unpacked product)
-
The drug is intended for the treatment of adult patients infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR
Manufacturer: Emcure Pharmaceuticals Ltd